BioSpace

Pfizer snags $1.5B financing from PE firm Blackstone to support Metsera asset

With 10 active or planned Phase 3 trials underway for Metsera’s berobenatide, Pfizer has signed a deal with Blackstone Life Sciences to finance the program to approval.

By BioSpace

1 min read
Pfizer snags $1.5B financing from PE firm Blackstone to support Metsera asset
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights